Related Experiment Video
Updated: Jun 1, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Molecular complexity and fragment-based drug discovery: ten years on
Andrew R Leach1, Michael M Hann
1Computational & Structural Chemistry, GlaxoSmithkline Research and Development, Gunnels Wood Road, Stevenage, Herts. SG1 2NY, United Kingdom.
Abstract:
We review the concept of molecular complexity in the context of the very simple model of molecular interactions that we introduced over ten years ago. A summary is presented of efforts to validate this simple model using screening data. The relationship between the complexity model and the problem of sampling chemical space is discussed, together with the relevance of these theoretical concepts to fragment-based drug discovery.
Related Concept Videos
Drug Discovery: Overview
Sanger Sequencing
Modern Molecular Taxonomy
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Pharmacogenomics: Identification of New Drug Targets
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...

